Physician profile
Robert W Doidge
NPI 1326113416
$8,036.45
in general payments reported to CMS, 2019-2025
15 companies · $409 in 2025
The $409 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.90 · 2020: $57.03 · 2021: $1,638 · 2022: $1,222 · 2023: $2,328 · 2024: $2,320 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,056.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $3,044.01 | 2021-2025 | Milagro, Dynatape, Healix Knotless Peek |
| Anika Therapeutics, INC. | $2,384.61 | 2021-2024 | Integrity, Revomotion |
| Ossio INC | $848.54 | 2023-2024 | |
| Seapearl East, INC | $520.08 | 2020-2024 | |
| Geistlich Pharma, North America, INC. | $354.66 | 2023 | Bio-Materials |
| Miach Orthopaedics, INC. | $238.37 | 2024 | |
| Kerecis Limited | $184.61 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Zimmer Biomet Holdings, INC. | $173.03 | 2019-2023 | Tapestry |
| Stryker Corporation | $106.32 | 2021 | |
| Vericel Corporation | $44.05 | 2025 | Maci |
| Ermi LLC | $41.28 | 2019-2020 | |
| Medical Device Business Services, INC. | $32.86 | 2023 | Fms |
| Electronic Waveform Lab, INC. | $30.38 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $19.12 | 2025 | |
| Zyla Life Sciences, INC. | $14.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Doidge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.